Ac immune receives fda fast track designation for anti-amyloid-beta active immunotherapy, aci-24.060, to treat alzheimer's disease

Ac immune receives fda fast track designation for anti-amyloid- beta active immunotherapy , aci-24.060, to treat alzheimer's disease

ACIU Ratings Summary

ACIU Quant Ranking